⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8266887 | 0.81 | — | — | |
| SCHEMBL8266884 | 0.80 | — | — | |
| SCHEMBL13620736 | 0.80 | — | — | |
| SCHEMBL18404524 | 0.80 | — | — | |
| SCHEMBL24649582 | 0.76 | — | — | |
| SCHEMBL21261030 | 0.76 | — | — | |
| SCHEMBL14517550 | 0.74 | — | — | |
| SCHEMBL17552314 | 0.74 | — | — | |
| SCHEMBL24225654 | 0.74 | — | — | |
| SCHEMBL13282614 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200361920-A1 | ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF | ENANTA PHARMACEUTICALS, INC. | 2020-11-19 | — | — | US | disclosed |
| EP-3179303-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2017-06-14 | — | — | EP | disclosed |
| WO-2011103509-A1 | HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS | ACEA BIOSCIENCES INC. (US) | 2011-08-25 | — | — | WO | disclosed |